A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial

Overview of attention for article published in Patient related outcome measures, October 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,137 followers.

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of #NeuroendocrineTumor Patients with #CarcinoidSyndrome @DovePress https://t.co/BlFQvpDyWd

Reply Repost Favourite